388 related articles for article (PubMed ID: 35261277)
1. Prognostic Cardiac Magnetic Resonance Markers of Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy for Predicting Heart Failure Outcomes.
Chun KH; Oh J; Hong YJ; Yu HT; Lee CJ; Kim TH; Joung B; Pak HN; Lee MH; Kim YJ; Kang SM
J Am Heart Assoc; 2022 Mar; 11(6):e023167. PubMed ID: 35261277
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular involvement assessed by LGE-CMR in predicting the risk of adverse outcomes of arrhythmogenic cardiomyopathy with ICDs.
Zhang N; Song Y; Hua W; Hu Y; Chen L; Cai M; Niu H; Cai C; Gu M; Zhao S; Zhang S
Int J Cardiol; 2021 Aug; 337():79-85. PubMed ID: 33839174
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of myocardial strain and late gadolinium enhancement on cardiovascular magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy with moderate to severely reduced ejection fraction.
Pi SH; Kim SM; Choi JO; Kim EK; Chang SA; Choe YH; Lee SC; Jeon ES
J Cardiovasc Magn Reson; 2018 Jun; 20(1):36. PubMed ID: 29898740
[TBL] [Abstract][Full Text] [Related]
5. Role of cardiac magnetic resonance in the differential diagnosis between arrhythmogenic cardiomyopathy with left ventricular involvement and previous infectious myocarditis.
Colombo D; Turco A; Lomi S; Valentini A; Bassi E; Scelsi L; Greco A; Schirinzi S; Zacchino M; Acquaro M; Oliveri F; Preda L; Ghio S
Int J Cardiol; 2023 Mar; 374():120-126. PubMed ID: 36535562
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.
Lin L; Li X; Feng J; Shen KN; Tian Z; Sun J; Mao YY; Cao J; Jin ZY; Li J; Selvanayagam JB; Wang YN
J Cardiovasc Magn Reson; 2018 Jan; 20(1):2. PubMed ID: 29298704
[TBL] [Abstract][Full Text] [Related]
7. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy.
Cadour F; Quemeneur M; Biere L; Donal E; Bentatou Z; Eicher JC; Roubille F; Lalande A; Giorgi R; Rapacchi S; Cortaredona S; Tradi F; Bartoli A; Willoteaux S; Delahaye F; Biene SM; Mangin L; Ferrier N; Dacher JN; Bauer F; Leurent G; Lentz PA; Kovacsik H; Croisille P; Thuny F; Bernard M; Guye M; Furber A; Habib G; Jacquier A
J Cardiovasc Magn Reson; 2023 Feb; 25(1):7. PubMed ID: 36747201
[TBL] [Abstract][Full Text] [Related]
9. Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.
Pöyhönen P; Kivistö S; Holmström M; Hänninen H
BMC Cardiovasc Disord; 2014 Aug; 14():110. PubMed ID: 25160650
[TBL] [Abstract][Full Text] [Related]
10. Implications of multiple late gadolinium enhancement lesions on the frequency of left ventricular reverse remodeling and prognosis in patients with non-ischemic cardiomyopathy.
Ota S; Orii M; Nishiguchi T; Yokoyama M; Matsushita R; Takemoto K; Tanimoto T; Hirata K; Hozumi T; Akasaka T
J Cardiovasc Magn Reson; 2021 Mar; 23(1):32. PubMed ID: 33761955
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular entropy is a novel predictor of major adverse cardiac events (MACE) in patients with coronary atherosclerosis: a multi-center study.
Wang WX; Gao Y; Wang J; Liu MX; Gu H; Yuan XS; Wang XM
Eur Radiol; 2024 May; 34(5):3411-3421. PubMed ID: 37889269
[TBL] [Abstract][Full Text] [Related]
12. The Extent of Late Gadolinium Enhancement Can Predict Adverse Cardiac Outcomes in Patients with Non-Ischemic Cardiomyopathy with Reduced Left Ventricular Ejection Fraction: A Prospective Observational Study.
Kim EK; Lee GY; Jang SY; Chang SA; Kim SM; Park SJ; Choi JO; Park SW; Choe YH; Lee SC; Oh JK
Korean J Radiol; 2021 Mar; 22(3):324-333. PubMed ID: 32932562
[TBL] [Abstract][Full Text] [Related]
13. Regional Strain by Cardiac Magnetic Resonance Imaging Improves Detection of Right Ventricular Scar Compared With Late Gadolinium Enhancement on a Multimodality Scar Evaluation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
Zghaib T; Ghasabeh MA; Assis FR; Chrispin J; Keramati A; Misra S; Berger R; Calkins H; Kamel I; Nazarian S; Zimmerman S; Tandri H
Circ Cardiovasc Imaging; 2018 Sep; 11(9):e007546. PubMed ID: 30354675
[TBL] [Abstract][Full Text] [Related]
14. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH
J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
[TBL] [Abstract][Full Text] [Related]
15. T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides.
Greulich S; Mayr A; Kitterer D; Latus J; Henes J; Steubing H; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Braun N; Alscher MD; Sechtem U; Mahrholdt H
J Cardiovasc Magn Reson; 2017 Jan; 19(1):6. PubMed ID: 28077133
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping.
Liang YD; Xu YW; Li WH; Wan K; Sun JY; Lin JY; Zhang Q; Zhou XY; Chen YC
J Cardiovasc Magn Reson; 2020 Jan; 22(1):2. PubMed ID: 31902370
[TBL] [Abstract][Full Text] [Related]
17. Does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?
Gulsin GS; Shetye A; Khoo J; Swarbrick DJ; Levelt E; Lai FY; Squire IB; Arnold JR; McCann GP
BMC Cardiovasc Disord; 2017 Apr; 17(1):98. PubMed ID: 28390413
[TBL] [Abstract][Full Text] [Related]
18. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.
Wu KC; Weiss RG; Thiemann DR; Kitagawa K; Schmidt A; Dalal D; Lai S; Bluemke DA; Gerstenblith G; Marbán E; Tomaselli GF; Lima JA
J Am Coll Cardiol; 2008 Jun; 51(25):2414-21. PubMed ID: 18565399
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Right Ventricular Function in Patients With Suspected Myocarditis Undergoing Cardiac Magnetic Resonance.
Bernhard B; Schnyder A; Garachemani D; Fischer K; Tanner G; Safarkhanlo Y; Stark AW; Schütze J; Pavlicek-Bahlo M; Greulich S; Johner C; Wahl A; Benz DC; Kwong RY; Gräni C
JACC Cardiovasc Imaging; 2023 Jan; 16(1):28-41. PubMed ID: 36599567
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Late Gadolinium Enhancement in Nonischemic Cardiomyopathy.
Gaztanaga J; Paruchuri V; Elias E; Wilner J; Islam S; Sawit S; Viles-Gonzalez J; Sanz J; Garcia MJ
Am J Cardiol; 2016 Oct; 118(7):1063-8. PubMed ID: 27614850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
